Literature DB >> 19777213

Determining the subjective and physiological effects of BZP on human females.

Joanne C Lin1, Nisha Bangs, Heeseung Lee, Rob R Kydd, Bruce R Russell.   

Abstract

BACKGROUND: "Party pills" containing benzylpiperazine (BZP) used to be widely and legally available as recreational drugs in New Zealand. There are only two published trials on human subjects (1973), which suggested that 100 mg of BZP produced subjective and physiological effects similar to 10 mg of dexamphetamine. The purpose of this study is to further investigate the subjective and physiological responses to BZP in females. METHODS/STUDY
DESIGN: In a randomised, double blind, placebo-controlled study, the subjective and physiological effects of BZP were investigated in 27 healthy, right-handed non-smoking females (mean age 22 +/- 3 years). Two groups were tested before and approximately 120 minutes after administration of a single oral dose of either 200 mg BZP (n = 14) or placebo (n = 13). Participants were required to comment on the subjective effects of BZP using three rating scales-the Addiction Centre for Research Inventory, the Profile of Mood States and the Visual Analogue Scale. Participants' blood pressure, heart rate and temperature were also measured. RESULTS/
FINDINGS: Statistical analysis using a split-plot analysis of variance and t tests revealed that BZP significantly increases blood pressure and heart rate (p < 0.05) Likewise, the subjective reports revealed that BZP has significant stimulant effects, increases euphoria and dysphoria and increases sociability and drug liking (p < 0.05). DISCUSSION/
INTERPRETATION: Physiological and subjective data reflected a clear similarity between the effects of BZP and those of other commonly known stimulants such as amphetamine and 3,4-methylenedioxymethamphetamine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19777213     DOI: 10.1007/s00213-009-1669-2

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  36 in total

Review 1.  Healthy nightclubs and recreational substance use. From a harm minimisation to a healthy settings approach.

Authors:  Mark A Bellis; Karen Hughes; Helen Lowey
Journal:  Addict Behav       Date:  2002 Nov-Dec       Impact factor: 3.913

2.  Intermittent, chronic fenfluramine administration to rats repeatedly suppresses food intake despite substantial brain serotonin reductions.

Authors:  SuJean Choi; Elizabeth M Jonak; Lynn Simpson; Vaishali Patil; John D Fernstrom
Journal:  Brain Res       Date:  2002-02-22       Impact factor: 3.252

3.  Studies on the biochemical mode of action of EGYT-475, a new antidepressant.

Authors:  K Tekes; L Tóthfalusi; B Malomvölgyi; F Hermán; K Magyar
Journal:  Pol J Pharmacol Pharm       Date:  1987 Mar-Apr

4.  A comparison of the subjective and cardiovascular effects of cocaine and lidocaine in humans.

Authors:  M W Fischman; C R Schuster; Y Hatano
Journal:  Pharmacol Biochem Behav       Date:  1983-01       Impact factor: 3.533

5.  Involvement of hypothalamic neuropeptide Y in regulating the amphetamine-induced appetite suppression in streptozotocin diabetic rats.

Authors:  Dong-Yih Kuo
Journal:  Regul Pept       Date:  2005-04-15

Review 6.  Alpha(2)-adrenergic receptor signalling in hypertension.

Authors:  Nancy L Kanagy
Journal:  Clin Sci (Lond)       Date:  2005-11       Impact factor: 6.124

7.  Party pills and drug-drug interactions.

Authors:  Meghan Murphy; Ushtana Antia; Hsin-Yao Chang; Jae Young Han; Ushtana Ibrahim; Malcolm Tingle; Bruce Russell
Journal:  N Z Med J       Date:  2009-04-24

Review 8.  Effects of eating behavior on mood: a review of the literature.

Authors:  L Christensen
Journal:  Int J Eat Disord       Date:  1993-09       Impact factor: 4.861

9.  Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP.

Authors:  Manuel Tancer; Chris-Ellyn Johanson
Journal:  Drug Alcohol Depend       Date:  2003-10-24       Impact factor: 4.492

10.  Acute tolerance development to the cardiovascular and subjective effects of cocaine.

Authors:  M W Fischman; C R Schuster; J Javaid; Y Hatano; J Davis
Journal:  J Pharmacol Exp Ther       Date:  1985-12       Impact factor: 4.030

View more
  9 in total

1.  Effects of trifluoromethylphenylpiperazine (TFMPP) on interhemispheric communication.

Authors:  HeeSeung Lee; Rob R Kydd; Vanessa K Lim; Ian J Kirk; Bruce R Russell
Journal:  Psychopharmacology (Berl)       Date:  2010-10-06       Impact factor: 4.530

2.  Reinstatement of extinguished amphetamine self-administration by 3,4-methylenedioxymethamphetamine (MDMA) and its enantiomers in rhesus monkeys.

Authors:  Jessica McClung; William Fantegrossi; Leonard L Howell
Journal:  Psychopharmacology (Berl)       Date:  2010-03-23       Impact factor: 4.530

3.  Psychoactive Substances Bill and Act of New Zealand: A Chance to Engage Undergraduate Scientists with Society using a Transfer Learning Paradigm.

Authors:  Catherine M Gliddon; Belinda Cridge
Journal:  J Undergrad Neurosci Educ       Date:  2015-10-15

4.  Acute effects of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) using functional magnetic resonance imaging (fMRI) and the Stroop task--a pilot study.

Authors:  Louise E Curley; Rob R Kydd; Michelle C Robertson; Avinesh Pillai; Nicolas McNair; HeeSeung Lee; Ian J Kirk; Bruce R Russell
Journal:  Psychopharmacology (Berl)       Date:  2015-04-19       Impact factor: 4.530

5.  Determining the subjective effects of TFMPP in human males.

Authors:  Reem K Jan; Joanne C Lin; Heeseung Lee; Janie L Sheridan; Rob R Kydd; Ian J Kirk; Bruce R Russell
Journal:  Psychopharmacology (Berl)       Date:  2010-06-16       Impact factor: 4.530

6.  Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users.

Authors:  Tibor M Brunt; Maarten W Koeter; Raymond J M Niesink; Wim van den Brink
Journal:  Psychopharmacology (Berl)       Date:  2011-10-13       Impact factor: 4.530

7.  Determining the subjective and physiological effects of BZP combined with TFMPP in human males.

Authors:  Joanne C Lin; Reem K Jan; HeeSeung Lee; Maree-Ann Jensen; Rob R Kydd; Bruce R Russell
Journal:  Psychopharmacology (Berl)       Date:  2011-04       Impact factor: 4.530

8.  Acute effects of BZP, TFMPP and the combination of BZP and TFMPP in comparison to dexamphetamine on an auditory oddball task using electroencephalography: a single-dose study.

Authors:  HeeSeung Lee; Grace Y Wang; Louise E Curley; John J Sollers; Rob R Kydd; Ian J Kirk; Bruce R Russell
Journal:  Psychopharmacology (Berl)       Date:  2015-12-03       Impact factor: 4.530

9.  Differential responses to anticipation of reward after an acute dose of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) alone and in combination using functional magnetic resonance imaging (fMRI).

Authors:  Louise E Curley; Robert R Kydd; Ian J Kirk; Bruce R Russell
Journal:  Psychopharmacology (Berl)       Date:  2013-05-11       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.